Alisa Lask is the new vice president and general manager of Galderma’s Aesthetic & Corrective Business unit in the U.S. Chris Chapman has been named vice president and general manager of the company’s Prescription Business unit in the U.S.
Lask, who previously served as vice president of marketing in the Aesthetics & Corrective unit, will manage Galderma's portfolio of aesthetic treatments, including Restylane and Sculptra Aesthetic. Prior to joining Galderma, she worked in global marketing for facial aesthetics at Allergan, served as vice president of global strategic marketing at Zimmer Biomet and spent 11 years at Eli Lilly specializing in marketing for women’s health and neuroscience.
Chapman previously served as vice president of strategic access for Galderma’s Prescription Business unit. In his new role, he will manage Galderma’s portfolio of prescription medications including the full line of products for acne, psoriasis, eczema and rosacea. He will also oversee Galderma CareConnect, a patient savings card program that he developed and launched after joining the company in 2015.
Image: Chris Chapman
